Positive Trial Results for Pharvaris, Roivant, and Genflow Biosciences
Several biotech companies reported positive clinical trial data, including Pharvaris' drug for hereditary angioedema, Roivant's mosliciguat, and Genflow's SLAB trial, boosting their stock prices.